|
|
|
TD2 Service Offering
TGen Drug Development Services (TD2) offers cost-reduction programs through advanced technology and economies-of-scale, along with comprehensive billing to accommodate your budget parameters. The complete service offering includes:
In Vitro Evaluation of Anticancer Agents
- Apoptosis Studies
- Potency Testing
- Dosing Studies
- Human Tumor Cloning Assays
- Target Detection (IHC, In vivo imaging, microarray)
DNA/RNA Quantitative PCR
- Biodistribution analysis for gene therapy studies
- Custom assays available upon request
In Vivo Efficacy Evaluation
- Human Tumor Xenograft Models
- Acute Toxicity
- Pharmacokinetics
Formulation Development
- Preparation of dosing formulations of test articles
- Non-GLP/GMP stability studies
Genomics Support
- Tissue Microarrays
- DNA Sequencing
- Gene Expression Profiling
- RNAi
- In Situ Hybridization Gene Expression Profiling
Clinical Trials
- Feasibility Studies
- Investigator Selection Strategies
- Phase I, II, and III Study Design by Medical Oncologists
- Trial Coordination
- PCRT - a multi-institutional clinical trial organization specializing in pancreatic cancer (Phase I, II and III)
- We also have access to services offered through The Molecular Profiling Institute's Tissue Banking and Analysis Center
|
|
|
|
